GRADE evidence profile for participants in randomised controlled trials (RCTs) compared with eligible non-participants who received similar treatment

 

 

Outcome

No of comparisons

Design

Study limitations

Consistency

Directness*

No of patients in RCT

No. of patients outside RCT

Relative effect (95% CI)

Overall quality

Dichotomous

73

Observational

No serious limitations†

Important inconsistencies‡

Direct

30 458

19 640

0.94 (0.87 to 1.02)

Very low

Continuous

18

Observational

No serious limitations†

No important inconsistencies

Direct

713

764

0.01 (-0.10 to 0.12)§

Low

Mortality

32

Observational

No serious limitations†

Important inconsistencies‡

Direct

26 406

16 609

1.00 (0.91 to 1.09)

Very low

GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:14.

*Studies vary widely in terms of participants, interventions, and outcome measures; directness (applicability) of overall results to any specific trial is difficult to assess, particularly in light of unexplained heterogeneity of results.

†Although many studies were poorly controlled, differences in risk of bias did not seem to be related to differences in results, and overall results are consistent with results for studies without serious limitations.

‡Important, unexplained, statistically significant heterogeneity.

§Standardised mean difference (95% confidence interval).




Access jobs at BMJ Careers
Whats new online at Student 

BMJ